Prospective study including Mexican patients diagnosed with type 2 diabetes and class 1 obesity, undergoing laparoscopic gastric bypass. The objective was to determine short, mid-and long-term outcomes (weight loss, metabolic, morbidity and diabetes remission). A subanalysis was included, based on preoperative usage of one (Group A) or more antidiabetics ± insulin (Group B).
Study Type
OBSERVATIONAL
Enrollment
51
The LGBP was performed using a classic Roux-en-Y procedure. Briefly, a gastric pouch of 30-50 cc was constructed with an antecolic calibrated gastro-jejunal anastomosis (mechanical anastomosis using a 2.5 mm load). The biliary and alimentary limbs measured ≈70 cm and ≈150 cm, respectively, and the jejuno-jejunal anastomosis was also performed in a latero-lateral fashion (mechanical anastomosis using a 2.5 mm load). Mesenteric defects were closed with running non-absorbable sutures and the omentum was divided in every case
Hospital General Tlahuac
Mexico City, Mexico
Weight Loss
Measure: weight (kilograms)
Time frame: 12 months
Weight Loss
Measure: weight (kilograms)
Time frame: 24 months
Weight Loss
Measure: weight (kilograms)
Time frame: 36 months
Weight Loss
Measure: Body Mass Index
Time frame: 12 months
Weight Loss
Measure: Body Mass Index
Time frame: 24 months
Weight Loss
Measure: Body Mass Index
Time frame: 36 months
Weight Loss
Measure: % excess weight loss
Time frame: 12 months
Weight Loss
Measure: % excess weight loss
Time frame: 24 months
Weight Loss
Measure: % excess weight loss
Time frame: 36 months
Weight Loss
Measure: % total weight loss
Time frame: 12 months
Weight Loss
Measure: % total weight loss
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 24 months
Weight Loss
Measure: % total weight loss
Time frame: 36 months
Complete Diabetes Remission
Definition: no antidiabetic drugs while on glucose \<100 mg/dl and HbA1C% \<6
Time frame: 12 months
Complete Diabetes Remission
Definition: no antidiabetic drugs while on glucose \<100 mg/dl and HbA1C% \<6
Time frame: 24 months
Complete Diabetes Remission
Definition: no antidiabetic drugs while on glucose \<100 mg/dl and HbA1C% \<6
Time frame: 36 months
Late complications
Complications requiring re-admssion / re-operation
Time frame: After 30 days from surgery
Early complications
Complications requiring re-admssion / re-operation
Time frame: First 30 days after surgery